US Patent Issued to JANSSEN BIOTECH on Dec. 9 for "Materials and methods for producing bioengineered virus specific lymphocytes" (Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,226, issued on Dec. 9, was assigned to JANSSEN BIOTECH INC. (Horsham, Pa.).

"Materials and methods for producing bioengineered virus specific lymphocytes" was invented by Rajkumar Ganesan (Blue Bell, Pa.), Sanjaya Singh (Blue Bell, Pa.) and Iqbal S. Grewal (Newtown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for activating or enriching VBeta17+CD8+ T cells, comprising contacting a M1 peptide derived from human influenza A virus (M158-66) with a population of cells comprising T cells."

The patent was filed on Aug. 9, 2021, under Application No. 17/397,174.

*For further information, including images, charts and tables, please visit: ...